Expleo Solutions Complete Financial Statements
12 Years of Data
2026 - 2015
In FY2026, Expleo Solutions (EXPLEOSOL) reported revenue ₹301 Cr, net profit ₹42 Cr and EPS ₹26.85, with a net profit margin of 14.0% and ROE of 5.4%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review EXPLEOSOL price earnings ratio to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Net Profit Margin
13.95%
2026 data
EBITDA Margin
18.94%
2026 data
Operating Margin
15.00%
2026 data
Return on Assets
4.52%
2026 data
Return on Equity
5.41%
2026 data
Balance Sheet Ratios
Current Ratio
29.63
2026 data
Equity Ratio
83.53%
2026 data
Asset Turnover
0.32
2026 data
EXPLEOSOL Revenue, Net Profit & EBITDA — Year-on-Year Growth
EXPLEOSOL YoY (Mar 2025 vs Mar 2026) — revenue +15.8%, net profit +75.0%, EBITDA +26.7%, expenses +13.0%. For live price, earnings ratios and company overview, see Expleo Solutions screener.
Revenue Growth
+15.8%
Year-over-Year
Net Profit Growth
+75.0%
Year-over-Year
EBITDA Growth
+26.7%
Year-over-Year
Expense Growth
+13.0%
Year-over-Year
Assets Growth
+11.8%
Year-over-Year
Equity Growth
+22.0%
Year-over-Year
Operating Cash Flow Growth
+152.1%
Year-over-Year
Investing Cash Flow Growth
-54.5%
Year-over-Year
Financing Cash Flow Growth
-480.0%
Year-over-Year
EXPLEOSOL Income Statement — Revenue, EBITDA & Net Profit
Expleo Solutions revenue ₹301 Cr, EBITDA ₹57 Cr, net profit ₹42 Cr, EPS ₹26.85 (2026) — net profit margin 14.0%. Explore EXPLEOSOL investment value to estimate fundamental worth using multiple valuation models.
Periods
₹ Crores
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 301 | 295 | 260 | 267 | 290 | 272 | 257 | 254 | 260 | 236 | 235 | 226 | 227 | 262 | 220 | 201 | 213 | 254 | 98 | 80 | 92 | 106 | 75 | 79 | 77 | 77 | 66 | 67 | 62 | 73 | 81 | 79 | 74 | 71 | 72 | 58 | 64 | 71 | 69 | 72 | 74 | 61 | 69 | 53 | 63 | 67 |
| Expenses | 244 | 236 | 216 | 230 | 250 | 217 | 221 | 213 | 219 | 200 | 188 | 194 | 192 | 212 | 178 | 166 | 176 | 168 | 81 | 63 | 73 | 89 | 56 | 60 | 57 | 58 | 51 | 53 | 51 | 57 | 59 | 63 | 60 | 62 | 59 | 50 | 48 | 62 | 58 | 56 | 58 | 53 | 52 | 49 | 48 | 55 |
| EBITDA | 57 | 59 | 45 | 37 | 40 | 55 | 36 | 41 | 41 | 36 | 47 | 32 | 35 | 50 | 43 | 36 | 38 | 86 | 17 | 17 | 19 | 18 | 19 | 19 | 21 | 18 | 15 | 14 | 12 | 16 | 22 | 16 | 14 | 9 | 12 | 8 | 16 | 10 | 11 | 17 | 16 | 8 | 17 | 4 | 14 | 13 |
| Operating Profit Margin % | 15.00% | 17.00% | 16.00% | 11.00% | 10.00% | 16.00% | 13.00% | 15.00% | 15.00% | 14.00% | 19.00% | 14.00% | 15.00% | 15.00% | 19.00% | 15.00% | 17.00% | 30.00% | 17.00% | 21.00% | 17.00% | 16.00% | 24.00% | 21.00% | 26.00% | 19.00% | 22.00% | 19.00% | 17.00% | 17.00% | 22.00% | 15.00% | 17.00% | 11.00% | 15.00% | 14.00% | 20.00% | 13.00% | 16.00% | 23.00% | 21.00% | 12.00% | 22.00% | 7.00% | 17.00% | 19.00% |
| Depreciation | 6 | 7 | 8 | 8 | 7 | 10 | 9 | 9 | 12 | 8 | 7 | 8 | 8 | 8 | 7 | 5 | 7 | 7 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 51 | 51 | 36 | 28 | 32 | 45 | 26 | 31 | 28 | 27 | 39 | 24 | 26 | 41 | 36 | 30 | 31 | 77 | 15 | 15 | 17 | 15 | 17 | 17 | 19 | 17 | 13 | 13 | 10 | 14 | 21 | 15 | 12 | 8 | 11 | 7 | 14 | 8 | 10 | 16 | 15 | 6 | 16 | 3 | 13 | 12 |
| Tax | 9 | 12 | 11 | 8 | 10 | 9 | 11 | 7 | 9 | 6 | 10 | 5 | 6 | 7 | 12 | 9 | 8 | 22 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 3 | 4 | 7 | 4 | 4 | 3 | 4 | 2 | 5 | 3 | 3 | 5 | 5 | 2 | 6 | 1 | 4 | 4 |
| Net Profit | 42 | 40 | 24 | 20 | 22 | 36 | 16 | 24 | 20 | 21 | 29 | 18 | 20 | 34 | 24 | 22 | 23 | 55 | 11 | 11 | 13 | 11 | 13 | 14 | 14 | 13 | 9 | 9 | 7 | 10 | 14 | 10 | 8 | 5 | 7 | 5 | 9 | 5 | 6 | 11 | 9 | 4 | 10 | 2 | 9 | 7 |
| Earnings Per Share (₹) | 26.85 | 25.62 | 15.51 | 13.16 | 14.26 | 22.86 | 10.12 | 15.40 | 12.75 | 13.22 | 18.73 | 11.88 | 13.01 | 21.93 | 15.44 | 14.01 | 14.79 | 35.67 | 10.80 | 10.72 | 12.50 | 11.10 | 12.27 | 13.48 | 13.91 | 12.30 | 8.55 | 8.71 | 6.20 | 9.96 | 12.74 | 9.66 | 7.82 | 4.52 | 6.87 | 4.31 | 8.43 | 4.96 | 5.65 | 9.97 | 8.64 | 3.72 | 9.69 | 1.57 | 8.24 | 6.94 |
EXPLEOSOL Balance Sheet — Assets, Liabilities & Shareholders' Equity
EXPLEOSOL total assets ₹929 Cr, total equity ₹776 Cr, total liabilities ₹ Cr (2026) — ROE 5.4%.
Years
Annual Data
₹ Crores
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 929 | 831 | 765 | 730 | 594 | 264 | 214 | 192 | 191 | 171 | 182 | 165 |
| Current Assets | 711 | 563 | 598 | 553 | 449 | 226 | 177 | 163 | 163 | 138 | 153 | 138 |
| Fixed Assets | 73 | 113 | 131 | 142 | 108 | 25 | 26 | 19 | 22 | 27 | 25 | 24 |
| Capital Work in Progress | 0 | 0 | 5 | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 719 | 614 | 582 | 480 | 240 | 188 | 174 | 169 | 144 | 157 | 139 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 24 | 51 | 50 | 32 | 25 | 8 | 8 | 1 | 0 | 0 | 0 | 7 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 776 | 636 | 611 | 530 | 395 | 202 | 152 | 139 | 129 | 127 | 109 | 102 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 10 | 10 | 11 | 11 | 11 | 11 | 11 |
| Reserves & Surplus | 761 | 620 | 596 | 515 | 379 | 192 | 142 | 128 | 118 | 116 | 98 | 91 |
EXPLEOSOL Cash Flow Statement — Operating, Investing & Financing
Expleo Solutions operating cash flow ₹179 Cr, investing ₹-51 Cr, financing ₹-87 Cr, net cash flow ₹41 Cr (2025).
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 179 | 71 | 23 | 24 | 66 | 17 | 41 | 25 | 42 | 58 | 33 |
| Investing Activities | -51 | -33 | -37 | 3 | -44 | -7 | 24 | -18 | -14 | 11 | -6 |
| Financing Activities | -87 | -15 | -7 | -10 | -3 | -29 | -26 | -31 | -31 | -39 | -11 |
| Net Cash Flow | 41 | 24 | -21 | 17 | 19 | -19 | 38 | -23 | -2 | 30 | 16 |